Washington: A new study has found no evidence of a cannabis constituent in the progress of multiple sclerosis.The first large non-commercial clinical study to investigate whether the main active constituent of cannabis (tetrahydrocannabinol or THC) is effective in slowing the course of progressive multiple sclerosis (MS), shows that there is no evidence to suggest this; although benefits were noted for those at the lower end of the disability scale.The CUPID (Cannabinoid Use in Progressive Inflammatory brain Disease) study was carried out by researchers from Plymouth University Peninsula Schools of Medicine and Dentistry.CUPID enrolled nearly 500 people with MS from 27 centres around the UK, and has taken eight years to complete.
Communal riots in Saharanpur fixed?
Glasgow: India`s golden girls shine at CWG
Petrol prices expected to fall by July 31
Delhi auto drivers on a day long strike against Delhi Police